Financials
Financial year 2025
AV Clinical Research from Schilde, company number BE0830746305, closed financial year 2025 with a result of € 39,272 after tax. For that financial year AV Clinical Research recorded a gross margin of € 59,661 and equity of € 166,699. Compared with financial year 2024, the result moved from € 30,003 to € 39,272. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.
€ 166,699
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 39,272
▲ 31% vs 2024
Profit after tax over the fiscal year.
€ 11,469
▼ 66% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 39,272 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 367
▼ 91% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,526
▲ € 1,503 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 33,048
▲ 171% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 84,285 | € 114,874 | € 51,758 | € 59,661 | ▲ 15% |
| Profit after taxes | € 60,976 | € 87,117 | € 30,003 | € 39,272 | ▲ 31% |
| Equity | € 153,373 | € 136,696 | € 166,699 | € 166,699 | |
| Total debts | € 56,199 | € 63,986 | € 12,200 | € 34,574 | ▲ 183% |
| Cash | € 65,997 | € 56,803 | € 33,871 | € 11,469 | ▼ 66% |
| Retained profit | € 140,373 | € 123,696 | € 153,699 | € 153,699 | |
| Dividend | € 55,580 | € 103,795 | € 0 | € 39,272 | |
| Balance sheet total | € 209,572 | € 200,681 | € 178,899 | € 201,273 | ▲ 13% |
Key figures of AV Clinical Research, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to AV Clinical Research?
What happened at AV Clinical Research in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 39,272 (▲ 31% vs 2024). Source: NBB ↗
- Anke Verheyen became a director. NBB
- New establishment in Schilde. KBO
- Start of the company according to the CBE. KBO
In short
From € 60,976 profit in 2022 to € 39,272 profit in 2025.
Paid € 88,770 in corporate taxes since 2022.
Best year ever: 2023, with € 87,117 profit.
Paid out € 198,646 in dividends to the owners in total.
Management
Behind AV Clinical Research is Anke Verheyen.
Directors
According to the 2025 annual accounts
Anke Verheyen
Director
since 2022
Establishments
Establishment units
Physical locations of this company
De Kluis 25A
2970 Schilde
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0830.746.305
- VAT number
- BE 0830.746.305
- Registered office
- De Kluis 25A, 2970 Schilde
- Names & denominations
- AV Clinical Research
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 October 2010
- Peppol
- Active · Active since 8 Jan 2026
- Activities · NACE
Overige technische testen en toetsen